We have investigated the effect of oxidatively-modi®ed low density lipoproteins (ox-LDL) on the contractility of rabbit trabecular smooth muscle. Low density lipoproteins (LDL) were isolated from fresh human plasma pooled from multiple donors and oxidized by exposure to copper. Corpus cavernosum strips from New Zealand White rabbits were studied in organ chambers for isometric tension measurement. Corporeal strips in which moderate tone was induced by phenylephrine, contracted when exposed to ox-LDL, but not when exposed to either native LDL (nLDL) or LDL protected from oxidation by butylated hydroxytoleune (BHT-LDL). Removal of the endothelium, or treatment of the corporeal strips with N o -nitro-L-arginine (nitric oxide synthase inhibitor), methylene blue of LY83583 (guanylate cyclase inhibitors/superoxide producing agents), did not prevent ox-LDL-induced contraction. ox-LDL, dose-dependently, enhanced the contractile response of corporeal strips to low and moderate concentrations by phenylephrine. nLDL had no signi®cant effect on phenylephrine-induced contraction of corporeal strips. ox-LDL, nLDL or BHT-LDL had no effect on relaxation induced by the endothelium-dependent dilator, acetylcholine, or the nitric oxide donor, nitroprusside.
Introduction
Many cases of impotence are associated with vascular risk factors such as diabetes, smoking, hypertension, hyperlipidemia, and atherosclerosis. 1 In the Massachusetts Male Aging Study, 2 patients with low levels of high density lipoproteins were at a higher risk of developing complete erectile dysfunction. Corpus cavernosum tissue from rabbits that are fed a high cholesterol diet shows impaired endothelium-dependent relaxation, decrease in nitric oxide synthase activity, increased electricallyinduced nerve mediated contractions and an increase in the output of constrictor prostanoids.
3±5
Low density lipoproteins (LDL), which are the major carriers of cholesterol in the blood, are known to be of primary importance in the development of coronary atherosclerosis, and it has been reported that oxydatively-modi®ed LDL (ox-LDL) inhibits endothelium-dependent relaxation of blood vessels and causes contraction of arteries. 6±9 It has also been shown that oxidation of LDL occurs in vivo, and ox-LDL has been detected in atherosclerotic lesions of rabbit and man. 10, 11 The purpose of this study was to de®ne the effects of ox-LDL on the contractility of rabbit corpus cavernosum smooth muscle.
Methods

Animals
All protocols were done in accordance with the guidelines for animal research provided by the NIH and the Helsinky Declaration of 1975, as revised in 1983. Male New Zealand White rabbits (3.0±3.5 kg of body weight) were anesthetized with sodium pentobarbital, exsanguinated and the penises were surgically removed en bloc. Once carefully dissected free from the surrounding tunica albunginea, the corporal tissue was immediately placed in PSS (see composition below) and suspended in organ chambers. 12 Each rabbit provided three to four strips of corpus cavernosum smooth muscle that were studied separately.
Drugs
All drugs and reagents were purchased from commercially available sources except for LY83583, that was a kind gift from Dr R Cohen, from Boston University, Boston, Massachusetts. Indomethacin was mixed in 0.1 M NaCO 3 and 0.1 M NaPO 4 (pH 6.9), other drugs were mixed in deionized distilled water. All drugs were kept at 4 C while in solution. To study cumulative concentration responses, drugs were added to the chamber in half-log concentration increments. Drugs were mixed so that for every concentration the volume added to chamber was between 8±100 ml.
Lipoprotein preparation
LDL was isolated by sequential ultracentrifugation from citrated fresh human plasma pooled from multiple donors. EDTA (1 mg/ml) was added to the plasma and its density was increased to 1.025 kg/L by adding solid KBr. After centrifugation for 18 h at 42 000 rpm, 15 C in an ultracentrifuge using a 55.2 Ti rotor (Beckman Instruments, Inc., Fullerton, CA), the infranatant was collected. The pooled infranatant was then adjusted to density 1.063 kg/ L, centrifuged as before and LDL (D 1.025± 1.063 Kg/L) was collected from the supernatant. In some preparations, before centrifugation the lipophilic antioxidant, butylated hydroxytoluene (BHT, 20 mM), was added directly to the plasma to avoid the oxidation of the lipoproteins. The purity and integrity of LDL preparations were controlled by agarose gel electrophoresis as previously described 8 ( Figure 1 ) and the protein concentration of LDL was determined by the method of Lowry. 13 Before each experiment, LDL was dialyzed at 4 C for 24 h against three changes of physiologic salt solution (PSS) gassed with 95% N 2 /5% CO 2 . LDL was oxidized by exposure to 5 mM CuSO 4 for 20 h in EDTA-free H 2 O at room temperature followed by dialysis at 4 C for 24 h against three changes of PSS. Copper-oxidized LDL has previously been shown to be indistinguishable from LDL which was biologically oxidized by endothelial cells in culture.
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Organ chamber studies Strips of corpus cavernosum tissue measuring approximately 2 mm 6 2 mm 6 10 mm were submerged in 8 ml organ chambers containing PSS. The strips were suspended with a wire to a force transducer on one end and ®xed with silk ties to a metallic support at the other end. Composition of the PSS was NaCl, 118.3 mM; KCl, 4.7 mM; MgSO 4 , 0.6 mM; KH 2 PO 4 , 1.2 mM; CaCl 2 , 2.5 mM; NaHCO 3 , 25 mM; calcium EDTA, 0.026 mM; and glucose, 11.1 mM. The solution was gassed with 95% air and 5% CO 2 . The pH of the solution was 7.4 and the temperature was maintained at 37 C. Isometric tension was measured with a force transducer (Grass FT03, Quincy, MA). The corpus cavernosum tissue was stepwise stretched for a period of more than one hour and the optimal resting isometric tension for contraction was determined. After every three stretches (less than 1.0 gm tension per stretch), the tissue was contracted with phenylephrine (3 6 10 76 M). When the amplitude of the contraction was within 10% of the previous one, that tension was considered optimal for isometric contraction. The preparations were ®rst exposed to KPSS, which was PSS with NaCl exchanged for KCl in equimolar basis, and the response was measured.
The direct effect of LDL on trabecular smooth muscle tone, were studied in strips at baseline tension and after a moderate amount of tone (approximately 30% of K -induced contraction) was induced with phenylephrine (10 77 to 3 6 10 77 M). Tissues were exposed to either native LDL (nLDL), oxidatively modi®ed LDL (ox-LDL) or BHT-treated LDL (100 mg/ml). The effect of the guanylate cyclase inhibitors/nitric oxide scavengers, methylene blue and LY83583, on ox-LDL-induced contractions was studied by exposing corporeal strips to these agents (10±15 min) prior to the addition of ox-LDL. In addition, the effects of nitric oxide synthase inhibition on ox-LDL-induced contraction was investigated by treating corporeal strips with N o -L-nitro arginine (10 74 M, 15 min) before exposing the tissues to ox-LDL. Finally, the possible implication of the endothelium on contraction induced by ox-LDL was investigated comparing 
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TY Ahn et al the responses in intact and endothelium-denuded preparations, as previously described. 14 Brie¯y, the removal of the endothelium from the lacunar spaces of the rabbit corpus cavernosum was achieved by treating the tissue with 3[(3-cholamidopropyl)-dimethylamonium]-1-propane sulfonate (CHAPS; 5 mg/ml) for 15 s through a 21G minicatheter, and then extensively washed with PSS. Strips derived from the CHAPS-treated tissue were contracted with phenylephrine and responses to ACh were tested. Only the strips that showed maximal relaxations of 15% or less, were considered to be denuded of endothelium.
The effect of LDL on agonist-induced contraction was investigated by performing concentration response curves to phenylephrine in time-control tissues, and in corporeal strips exposed to either ox-LDL (100 and 200 mg/ml) or n-LDL (200 mg/ml) for a period of 30 min.
All the experiments described above were performed in the presence of indomethacin (3 6 10 76 M) to inhibit prostanoid production.
Relaxations were studied following contraction with phenylephrine (3 6 10 76 M). Concentration response curves to endothelium-dependent and endothelium-independent relaxant agents, acetylcholine and sodium nitroprusside, respectively, were studied under control conditions and in the presence of LDL (100 mg/ml) after incubation for a period of 15±20 min.
Results
Direct effects of LDL on corpus cavernosum tone
Exposure of corpus cavernosum strips to n-LDL (100 mg/ml) or BHT-LDL (100 mg/ml) had no effect on basal tone nor was there an increase in tone after the tissues had been previously contracted with phenylephrine ( Figure 2 ). Exposure to ox-LDL (100 mg/ml) had either no effect or, inconsistently, caused a small increase in basal tone (Figure 3) . However, in tissues in which some degree of tone (approximately 30% of maximum potassium contraction) had been induced with phenylephrine, ox-LDL consistently provoked further contraction of the corporeal strips reaching a total amount of tone (phenylephrine plus ox-LDL) of 73 AE 11% of the maximum potassium contraction (n 19) (Figure 3 ).
Effects of endothelial removal, N
o -nitro-L--arginine, methylene blue, and LY83583, on contraction induced by ox-LDL Removal of the endothelium that lines the lacunar spaces or treatment of the corporeal strips with the nitric oxide synthase inhibitor, N o -nitro-L-arginine (10 74 M), inhibited the relaxation induced by acetylcholine, but had no effect on the contraction induced by ox-LDL (Figures 4 and 5) . Also, treatment of corporeal strips with the guanylate cyclase inhibitors/superoxide producing agents, methylene blue (2 6 10 75 M) or LY83583 (2 6 10 75 M), blocked the relaxation response to acetylcholine but had Figure 2 Representative tracings of the effects of ox-LDL, n-LDL and BHT-LDL (100 mg/ml) on corpus cavernosum strips contracted with phenylephrine (0.2±0.5 mM). For details see the methods section. Figure 3 Representative tracings comparing the effect of ox-LDL on cavernosal strips at baseline tension and after a moderate amount of tone was induced with phenylephrine (0.2±0.5 mM). Pre-existing tone was necessary to trigger the contraction induced by ox-LDL.
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Effect of ox-LDL on contraction induced by phenylephrine
Phenylephrine caused concentration-dependent contraction of corporeal strips. Pretreatment of corporeal strips with ox-LDL (50, 100 or 200 mg/ml) signi®-cantly, and dose dependently, augmented the contractile response to phenylephrine at low and intermediate doses, without affecting the maximum contraction achieved in response to phenylephrine ( Figure 6 ). Maximum contraction to 10 74 M phenylephrine was: 5.1 AE 0.7 g for control, 5.37 AE 0.2 g with 50 mg/ml of ox-LDL, 5.2 AE 0.6 g with 100 mg/ml of ox-LDL, and 5.21 AE 0.7 g with 200 mg/ml of ox-LDL). n-LDL (200 mg/ml) had no signi®cant effect on phenylephrine-induced contraction (n 4, data not shown).
Effect of LDL on endothelium-dependent relaxation to acetylcholine and relaxation to nitroprusside.
Exposure of corpus cavernosum strips to ox-LDL or n-LDL (100 mg/ml) had no signi®cant effect on the relaxation of corporeal strips in response to the endothelium dependent dilator, acetylcholine Figure 4 Effect of removal of endothelium on contractions induced by ox-LDL. ENDO (strips with intact endothelium), ENDO 7 (strips without endothelium). As shown in this representative tracing, the absence of endothelium did not prevent the contraction induced by ox-LDL. Effect of various doses of ox-LDL on the contractile response of cavernosal strips to cumulative doses of phenylephrine. *P`0.05; **P`0.005; ***P`0.001 vs control. ANOVA was the statistical test used for comparisons. For details on the protocol see methods section. Figure 7 Effect of ox-LDL and n-LDL on endothelium-dependent relaxation to acetylcholine. Strips contracted with phenylephrine and exposed to 100 mg/ml of ox-LDL or n-LDL or vehicle (control) for 15±20 min were exposed to cumulative concentrations of acetycholine. There was no signi®cant effect of the different treatments on the relaxation response to acetylcholine.
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Discussion
The present study demonstrates that oxidativelymodi®ed LDL alters the contractility of corporeal smooth muscle; it causes its contraction, if the muscle has a certain degree of tone, and it enhances the contractile response to adrenergic agonists. The pro-contractile effects of ox-LDL are speci®c to this modi®ed LDL molecule, since no such effects were observed, at the concentrations used in our studies, with either n-LDL or LDL protected from oxidation, BHT-LDL. These observations suggest the potential involvement of the scavenger LDL receptor (to which oxidatively modi®ed, but not n-LDL, is able to bind) as a mediator of the contractile effects of ox-LDL. Such a receptor has been identi®ed in rabbit smooth muscle. 15 Many studies have shown that ox-LDL inhibits receptor-mediated endothelium-dependent relaxation in arteries of various locations. 6±9 In fact, some investigators have proposed that the pro-contractile effect of ox-LDL is the result of the inhibition of the dilator in¯uence of the endothelium on the blood vessels and, as a consequence, the balance of forces tilting towards contraction. 6±9 In our study, 100 mg of ox-LDL, which consistently caused contraction of corporeal strips, had no effect on endothelium dependent-relaxation to acetylcholine, which excludes signi®cant inhibition by ox-LDL of receptorcoupled stimulation of endothelium-dependent relaxation. The lack of implication of the endothelium in the pro-contractile activity of ox-LDL is further supported by the observation that contraction by ox-LDL was also present in endothelium-denuded corporeal strips, as previously reported in some blood vessels. 16, 17 Furthermore, inhibition of the nitric oxide/cGMP pathway, which accounts for most, if not all, of the vasodilator activity of the endothelium in corpus cavernosum tissue, is not implicated in the pro-contractile activity of ox-LDL, since the nitric oxide synthase inhibitor, N o -nitro-Larginine, or the guanylate cyclase inhibitors/superoxide producing agents, methylene blue and LY83583, did not affect ox-LDL-induced contraction. In addition, relaxations induced by the nitric oxide donor, nitroprusside, which exerts its effects via cGMP accumulation, were unaffected by ox-LDL. Therefore, the activity of ox-LDL in corpus cavernosum tissue appears independent of endothelial function or the nitric oxide/cGMP pathway.
Ox-LDL has been shown to induce pre-proendothelin mRNA expression in endothelial cells and increase the release of this potent constrictor peptide. 18 It is unlikely that the effects observed in our study are mediated by the release of endothelin, since removal of the endothelium, the main source of this peptide in corpus cavernosum tissue, 19 had no effect on ox-LDL-induced contraction. The participation of a constrictor prostanoid can also be excluded, since all experiments were done in the presence of indomethacin at a concentration that has been shown to block prostanoid production in rabbit corporeal strips. 20 Taken together, these observations suggest that the pro-contractile effects of ox-LDL in corpus cavernosum tissue may be the consequence of the direct action of the lipoprotein on trabecular smooth muscle.
In smooth muscle preparations, ox-LDL has been shown to increase intracellular free calcium.
21±23
The transduction pathways that are involved in this effect have not been clearly de®ned.
21±23 Enhancement of phosphoinositide turnover and sensitization to calcium ions by cholesterol have been proposed as possible mechanisms. 24, 25 Our studies suggest that if calcium is mobilized in corpus cavernosum smooth muscle by ox-LDL, then the increase in itself, in most cases, is not suf®cient to trigger a constrictor response. If intracellular calcium has already been increased by the stimulation of an agonist (in our study phenylephrine) then ox-LDL can cause a strong contraction, which is added to the pre±existing tone. 8 Similar observations have been reported in the pig coronary artery, where ox-LDL-induced contraction was dependent on the degree of pre-existing induced tone. The calcium hypothesis could also explain why pre-treatment or corporeal smooth muscle with ox-LDL enhances Figure 8 Effect of ox-LDL and BHT-LDL on relaxation to the nitric oxide donor, nitroprusside. Strips contracted with phenylephrine and exposed to 100 mg/ml of ox-LDL or BHT-LDL or vehicle (control) for 15±20 min were exposed to cumulative concentrations of acetylcholine. There was no signi®cant effect of the different treatments on the relaxation response to nitroprusside.
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Conclusion
Epidemiologic, clinical and experimental studies have identi®ed an association between hypercholesterolemia and atherosclerosis and erectile dysfunction. 1±4 Because relaxation of penile smooth muscle is necessary to initiate and maintain penile erection, the pro-contractile effects of ox-LDL, could make the initiation and/or the maintenance of penile erection more dif®cult.
Oxidation of LDL occurs in vivo, 26 and ox-LDL has been identi®ed in arterial lesions in animals and humans, 10 suggesting a possible pathophysiological role for ox-LDL in vivo. The pro-contractile effects of ox-LDL would be added to a number of other pathological effects that hyperlipedemia and atherosclerosis have on erectile tissue and lead to erectile dysfunction, including impairment of endotheliumdependent relaxation of corporeal smooth muscle, reduced activity of the enzyme nitric oxide synthase, and development of corporeal atherosclerosis. 
